Sultamicillin
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 329477

CAS#: 76497-13-7 (free)

Description: Sultamicillin, also known as CP-49952 and VD 1827, is an oral form of the antibiotic combination (codrug or mutual prodrug) ampicillin/sulbactam. It contains esterified ampicillin and sulbactam and is marketed under a number of trade names,Unasyn from Pfizer. After absorption, sultamicillin releases ampicillin and sulbactam into the system, so all the antibacterial efficacy of sultamicillin is due to ampicillin and sulbactam. Ampicillin exerts antibacterial activity against sensitive organisms by inhibiting biosynthesis of cell wall mucopeptide where as sulbactam irreversibly inhibits most important beta-lactamases that occur in resistant strains.


Chemical Structure

img
Sultamicillin
CAS# 76497-13-7 (free)

Theoretical Analysis

MedKoo Cat#: 329477
Name: Sultamicillin
CAS#: 76497-13-7 (free)
Chemical Formula: C25H30N4O9S2
Exact Mass: 594.15
Molecular Weight: 594.654
Elemental Analysis: C, 50.50; H, 5.09; N, 9.42; O, 24.21; S, 10.78

Price and Availability

Size Price Availability Quantity
25mg USD 285
Bulk inquiry

Related CAS #: 76203-99-1 (HCl)   76497-13-7 (free)   83105-70-8 (tosylate)    

Synonym: Sultamicillin; CP-49,952; CP 49,952; CP49,952; CP-49952; CP 49952; CP49952. VD 1827

IUPAC/Chemical Name: (((2S,5R,6R)-6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carbonyl)oxy)methyl (2S,5R)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide

InChi Key: OPYGFNJSCUDTBT-PMLPCWDUSA-N

InChi Code: InChI=1S/C25H30N4O9S2/c1-24(2)17(29-20(32)16(21(29)39-24)27-19(31)15(26)12-8-6-5-7-9-12)22(33)37-11-38-23(34)18-25(3,4)40(35,36)14-10-13(30)28(14)18/h5-9,14-18,21H,10-11,26H2,1-4H3,(H,27,31)/t14-,15-,16-,17+,18+,21-/m1/s1

SMILES Code: O=C([C@@H](C(C)(C)S([C@]1([H])C2)(=O)=O)N1C2=O)OCOC([C@@H](C(C)(C)S[C@]3([H])[C@@H]4NC([C@H](N)C5=CC=CC=C5)=O)N3C4=O)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 594.65 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Kumar VJ, Gupta PB, Kumar KS, Ray UK, Sreenivasulu B, Kumar GS, Rao KR, Sharma HK, Mukkanti K. Identification, isolation and characterization of a new degradation product in sultamicillin drug substance. J Pharm Biomed Anal. 2011 Feb 20;54(3):582-7. doi: 10.1016/j.jpba.2010.09.016. PubMed PMID: 20934824.

2: Koytchev R, Ozalp Y, Erenmemisoglu A, Kunter U, Alpan RS. Effect of the formulation on the bioequivalence of sultamicillin: tablets and suspension. Arzneimittelforschung. 2004 Sep;54(9A):634-9. PubMed PMID: 15497673.

3: Sailer R, Arnold P, Erenmemişoğlu A, Martin W, Tamur U, Kanzik I, Hincal AA. Bioequivalence study of sultamicillin suspensions. Arzneimittelforschung. 2007;57(4):232-7. PubMed PMID: 17515294.

4: Topuz B, Katircioğlu O, Bayramoğlu I, Ardiç FN, Erbudak H. Low dose sultamicillin in acute sinusitis. Infez Med. 2002 Mar;10(1):45-8. PubMed PMID: 12700441.

5: Ferreira JB, Rapoport PB, Sakano E, Kós AO, Piltcher OB, Pignatari SS, Pinheiro SD, Mocellin M. Efficacy and safety of Sultamicillin (Ampicillin/Sulbactan) and Amoxicillin/Clavulanic acid in the treatment of upper respiratory tract infections in adults--an open-label, multicentric, randomized trial. Braz J Otorhinolaryngol. 2006 Jan-Feb;72(1):104-11. PubMed PMID: 16917560.

6: Pajchel G, Tyski S. Application of micellar electrokinetic chromatography to the determination of sultamicillin in oral pharmaceutical preparations. J Chromatogr A. 2002 Dec 6;979(1-2):315-21. PubMed PMID: 12498263.

7: Laviana L, Fernández-Marí F, Bayod M, Blanco D. HPLC for in-process control in the production of sultamicillin. J Pharm Biomed Anal. 2003 Feb 26;31(2):321-8. PubMed PMID: 12609671.

8: Dajani A. Use of ampicillin/sulbactam and sultamicillin in pediatric infections: a re-evaluation. J Int Med Res. 2001 Jul-Aug;29(4):257-69. Review. PubMed PMID: 11675898.

9: Lode H. Role of sultamicillin and ampicillin/sulbactam in the treatment of upper and lower bacterial respiratory tract infections. Int J Antimicrob Agents. 2001 Sep;18(3):199-209. Review. PubMed PMID: 11673031.

10: Abdullah B, Lazim NM, Salim R. The effectiveness of Tualang honey in reducing post-tonsillectomy pain. Kulak Burun Bogaz Ihtis Derg. 2015;25(3):137-43. doi: 10.5606/kbbihtisas.2015.00008. PubMed PMID: 26050853.

11: Mat Lazim N, Abdullah B, Salim R. The effect of Tualang honey in enhancing post tonsillectomy healing process. An open labelled prospective clinical trial. Int J Pediatr Otorhinolaryngol. 2013 Apr;77(4):457-61. doi: 10.1016/j.ijporl.2012.11.036. PubMed PMID: 23273638.

12: Moosdeen F. The role of sulbactam-ampicillin/sultamicillin in mixed infections. Int J Antimicrob Agents. 1999 Aug;12 Suppl 1:S1. PubMed PMID: 10526866.

13: Hu CQ, Yang MZ, Zhang DC, Liu W, Wu Q, Liang H, Jin SH. [Studies on sultamicillin hydrolysis]. Yao Xue Xue Bao. 1997 Jul;32(7):553-7. Chinese. PubMed PMID: 11596284.

14: Arredondo-García JL. Use of ampicillin/sulbactam (sultamicillin) in the management of pediatric infections. Introduction. Pediatr Infect Dis J. 1998 Mar;17(3 Suppl):S3. PubMed PMID: 9519906.

15: López EL, Rivas NA. Clinical use of sultamicillin (ampicillin/sulbactam) in children. Pediatr Infect Dis J. 1998 Mar;17(3 Suppl):S12-4; discussion S20-1. PubMed PMID: 9519909.

16: Argekar AP, Kunjir SS. Quantitative estimation of sultamicillin p-toluenesulfonate in pharmaceutical preparations by reverse-phase high performance liquid chromatography. J Pharm Biomed Anal. 1996 Dec;15(3):423-7. PubMed PMID: 8951704.

17: Chan KH, Bluestone CD, Tan LS, Reisinger KS, Blatter MM, Fall PA. Comparative study of sultamicillin and amoxicillin-clavulanate: treatment of acute otitis media. Pediatr Infect Dis J. 1993 Jan;12(1):24-8. PubMed PMID: 8417421.

18: Friedel HA, Campoli-Richards DM, Goa KL. Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1989 Apr;37(4):491-522. Review. Erratum in: Drugs 1989 Nov;38(5):followi. PubMed PMID: 2661196.

19: Hara K, Kobayashi H. Sultamicillin experiences in the field of internal medicine. APMIS Suppl. 1989;5:51-6. PubMed PMID: 2660872.

20: Göker K, Güvener O. Antibacterial effects of ofloxacin, clindamycin and sultamicillin on surgical removal of impacted third molars. J Marmara Univ Dent Fac. 1992 Sep;1(3):237-49. PubMed PMID: 1308784.